Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment

By Vehmanen L.   Saarto T.   Elomaa I.   Makela P.   Valimaki M.   Blomqvist C.  

European Journal of Cancer, Vol. 37, Iss. 18, 2001-12 ,pp. : 2373-2378

Elsevier

Access to resources Recommend Favorite

Adjuvant Ovarian Suppression Versus Chemotherapy for Premenopausal, Hormone-responsive Breast Cancer: Quality of Life and Efficacy Tradeoffs

By Elkin Elena   Weinstein Milton   Kuntz Karen   Bunnell Craig   Weeks Jane  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 25-34

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients - effect of adjuvant chemotherapy

By Poikonen P.   Saarto T.   Elomaa I.   Joensuu H.   Blomqvist C.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 43-48

Elsevier

Access to resources Recommend Favorite

Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane

By Okanami Yuko  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 182-188

Springer Publishing Company

Access to resources Recommend Favorite

Systemic adjuvant treatment for premenopausal node-negative breast cancer

By Castiglione-Gertsch M.   Gelber R.D.   O'Neill A.   Coates A.S.   Goldhirsch A.  

European Journal of Cancer, Vol. 36, Iss. 4, 2000-03 ,pp. : 549-550

Elsevier

Access to resources Recommend Favorite